What is the recommended dose of nystatin (antifungal medication) for oral candidiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nystatin Dosing for Oral Candidiasis

For mild oral candidiasis in adults and children, use nystatin suspension (100,000 units/mL) at a dose of 4-6 mL (400,000-600,000 units) four times daily for 7-14 days, swishing the medication in the mouth as long as possible before swallowing. 1, 2

Dosing Regimens

Standard Suspension Dosing

  • Adults and children: 4-6 mL (400,000-600,000 units) four times daily for 7-14 days 1, 2
  • Infants: 2 mL (200,000 units) four times daily, using a dropper to place half the dose in each side of the mouth 2
  • Premature/low birth weight infants: 1 mL four times daily has been shown effective in limited studies 2

Alternative Pastille Dosing

  • Adults and children: 1-2 nystatin pastilles (200,000 units each) four times daily for 7-14 days 1

Administration Technique

Critical administration points that affect treatment success:

  • Swish the suspension thoroughly throughout the mouth for as long as possible (at least 2 minutes) to ensure contact with all affected areas 3
  • Swallow the medication after swishing rather than spitting it out to treat potential esophageal involvement 3
  • In infants, avoid feeding for 5-10 minutes after administration 2
  • Continue treatment for at least 48 hours after symptoms resolve and cultures confirm eradication of Candida 2

When Nystatin is NOT Appropriate

For moderate to severe oral candidiasis, oral fluconazole 100-200 mg daily for 7-14 days is superior to nystatin and should be used instead. 1, 3

Key Limitations of Nystatin

  • Clinical cure rates with nystatin are only 32-54% compared to 87-100% with fluconazole 4, 5
  • Nystatin has suboptimal tolerability and higher relapse rates 3, 4
  • Fluconazole provides longer disease-free intervals before relapse (18% vs 44% relapse rate at day 28) 4

Disease Severity Algorithm

Mild disease (limited oral involvement, minimal symptoms):

  • First-line: Nystatin suspension 4-6 mL four times daily OR clotrimazole troches 10 mg five times daily for 7-14 days 1

Moderate to severe disease (extensive involvement, significant symptoms, immunocompromised):

  • First-line: Oral fluconazole 100-200 mg daily for 7-14 days 1
  • Nystatin should NOT be used as first-line therapy 3

Special Populations and Considerations

Denture-Related Candidiasis

  • Denture disinfection MUST accompany antifungal therapy for treatment success 1, 3
  • Nystatin alone without denture disinfection has poor efficacy 6

HIV-Infected Patients

  • Antiretroviral therapy is strongly recommended to reduce recurrent infections 1
  • For recurrent infections requiring suppression, use fluconazole 100 mg three times weekly rather than chronic nystatin 1

Refractory Disease

If nystatin fails after 7-14 days, escalate to:

  • Itraconazole solution 200 mg once daily 1
  • Posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily 1
  • Voriconazole 200 mg twice daily 1

Common Pitfalls to Avoid

  • Do not use nystatin for moderate-severe disease or immunocompromised patients - fluconazole is significantly more effective 3, 4, 5
  • Do not stop treatment when symptoms improve - continue for full 7-14 days and at least 48 hours after symptom resolution 2
  • Do not neglect proper swishing technique - inadequate contact time reduces efficacy 3
  • Do not forget denture disinfection - treating the infection without addressing denture contamination leads to treatment failure 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nystatin Treatment for Oral Thrush

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.